Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1420 ARTÍCULOS , VIENDO DEL 1366 AL 1380

Efficacy and Safety of Escitalopram and Citalopram for Agitation in Alzheimer's Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

da Silva AMP, Falcão L, Virgilio Ribeiro F, Ogasawara Donato K, Machado Magalhães PL, Nascimento MDVS, Leite M, Lee Han M, Quiroga DG, de Souza Franco E, de Sousa Maia MB.

J Geriatr Psychiatry Neurol. 2026 May;39(3):249-260. doi: 10.1177/08919887251369893. Epub 2025 Aug 22.

Efficacy and Safety of Lithium for Behavioral and Cognitive Symptoms in Alzheimer's Disease Dementia: A Systematic Review With Frequentist and Bayesian Meta-Analysis

Pereira da Silva AM, de Deus O, Ribeiro FV, Tudella GCN, Cabeça LS, Silva LL, Han ML, Franco JO, Costa JGP, Santos do Nascimento MDV, Andrade Fernandes JV, Franco ES, de Sousa Maia MB.

Am J Geriatr Psychiatry. 2026 Mar;34(3):371-385. doi: 10.1016/j.jagp.2025.10.001. Epub 2025 Oct 4.

Task-based fMRI brain activation in mild cognitive impairment and Alzheimer's disease: an ALE meta-analysis

Lee ZL, Li JJ, Siew SKH, Billaud CHA, Yu J.

Geroscience. 2026 Apr;48(2):3069-3096. doi: 10.1007/s11357-025-01850-z. Epub 2025 Aug 29.

IL-24 ameliorates cognitive dysfunction via the inhibition PERK-eIF2α Signaling pathway in Alzheimer's disease

Du Y, Zheng X, Yue X, Fu P, Diao J, Zhang A, Cheng H, Yang H, Bi J, Zhou Q, Wang P.

Int Immunopharmacol. 2026 Jan 15;169:116039. doi: 10.1016/j.intimp.2025.116039. Epub 2025 Dec 18.

Mind Your Mouth: Impact of Oral Bacteria on Alzheimer's Disease

Mohammed AI, Mohammed AI, Reynolds E.

J Oral Pathol Med. 2026 Jan;55(1):1-6. doi: 10.1111/jop.70111. Epub 2025 Dec 23.

Repurposing glucagon-like peptide-1 receptor agonists for the treatment of neurodegenerative disorders

Sabbagh MN, Cummings JL, Ballard C, van der Flier WM, Heneka MT, Holst JJ, Knudsen LB, Salloway S, Tansey MG, Drucker DJ.

Nat Aging. 2026 Jan;6(1):56-67. doi: 10.1038/s43587-025-01029-3. Epub 2025 Dec 19.

A Randomized Controlled Trial of the Safety and Efficacy of Dronabinol for Agitation in Alzheimer's Disease

Rosenberg PB, Amjad H, Burhanullah H, Nowrangi M, Vandrey R, Pierre MJ, Outen JD, Schultz M, Marano C, Agronin M, Wilkins JM, Harper D, Laffaye T, Reardon E, Turner K, Ozonsi R, Drury M, Nguyen A, Hasoğlu T, Cromwell J, Leoutsakos JM, Forester BP.

Am J Geriatr Psychiatry. 2026 Feb;34(2):167-179. doi: 10.1016/j.jagp.2025.10.011. Epub 2025 Nov 10.

Zinc transporter proteins in the retina as potential biomarkers for staging early Alzheimer's disease: Comparative analysis in human and mouse models

Mashkani SMH, Bishop D, Adlard PA, Mojtaba Golzan S.

Neurobiol Aging. 2026 Jan;157:26-35. doi: 10.1016/j.neurobiolaging.2025.09.010. Epub 2025 Oct 1.

Reconciling recommendations for ethical sharing of biomarker results with Alzheimer's disease research participants: A systematic review and qualitative synthesis

Webster H, Zelinsky M, Rico V, Martinez K, Sankary L.

J Alzheimers Dis. 2026 Mar;110(1):46-57. doi: 10.1177/13872877251392555. Epub 2025 Nov 5.

Neuropsychiatric signatures across the Alzheimer's disease continuum in Down syndrome and sporadic forms: A biomarker-driven comparison

Botella M, Estanga A, Ros N, Saldias J, Cañada M, García-Sebastián M, Larrea JÁ, Echeverria M, Garrido A, Altuna M.

J Alzheimers Dis. 2026 Feb;109(3):1508-1519. doi: 10.1177/13872877251407121. Epub 2025 Dec 30.

Association of neighborhood disadvantage with Alzheimer's disease pathology and the stability of blood-based biomarker performance

Myoraku A, Hausle I, Mila-Aloma M, Thropp P, Wang LA, Doraiswamy PM, Tosun D; Alzheimer’s Disease Neuroimaging Initiative*.

J Prev Alzheimers Dis. 2026 Feb;13(2):100445. doi: 10.1016/j.tjpad.2025.100445. Epub 2025 Nov 23.

Amyloid Clearance and Transient CSF Aβ40 Reduction in a Case of ARIA-E/H Following Lecanemab Treatment

Naeshiro Y, Kitani-Morii F, Kasai T, Tanaka E, Kobayashi F, Ohara T.

Intern Med. 2026 Apr 1;65(7):1056-1060. doi: 10.2169/internalmedicine.6070-25. Epub 2025 Aug 21.

Clinimetrics: Towards a diagnostic neuropsychology grounded in Alzheimer's disease

Ilardi CR.

J Neuropsychol. 2026 Mar;20(1):246-255. doi: 10.1111/jnp.70008. Epub 2025 Aug 13.

Identifying a combination of biomarkers to predict treatment response to nabilone for agitation in Alzheimer's disease - an exploratory post hoc analysis

Wang HJ, Ruthirakuhan M, Andreazza AC, Beroncal EL, Black SE, Gallagher D, Herrmann N, Kiss A, Verhoeff NPLG, Lanctôt KL.

Neurodegener Dis Manag. 2026 Apr-Jun;16(3):263-272. doi: 10.1080/17582024.2025.2587549. Epub 2025 Nov 11.

Potential beneficial effects of PD-1/PD-L1 blockade in Alzheimer's disease: a systematic review and meta-analysis of preclinical and clinical studies

Yoon J, Ha H, Lee HW, Kim S, Yu YM, Chun H.

Mol Psychiatry. 2026 Feb;31(2):1156-1166. doi: 10.1038/s41380-025-03413-2. Epub 2025 Dec 15.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias